申请人:ABT Holding Company
公开号:US09284277B2
公开(公告)日:2016-03-15
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are benzazepine compounds. These compounds are serotonin receptor (5-HT2c) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT2c) is desired (e.g. addiction, anxiety, depression, obesity, and others).
本发明一般涉及一系列化合物,包括含有这些化合物的药物组合物,以及将这些化合物和组合物用作治疗剂。更具体地说,本发明的化合物是苯并氮杂环化合物。这些化合物是5-羟色胺受体(5-HT2c)配体,可用于治疗需要调节5-羟色胺受体(5-HT2c)活性的疾病、障碍和病况(例如成瘾、焦虑、抑郁、肥胖等)。